2 weeks Ago By Defense World Staff
Invivyd ( NASDAQ:IVVD – Get Free Report ) will be announcing its earnings results before the market opens on Thursday, November 14th. Analysts expect the company to announce earnings of ($0.32) per share for the quarter.
Persons interested in participating in the company’s earnings conference call can do so using this link . Invivyd ( NASDAQ:IVVD – Get Free Report ) last posted its quarterly earnings data on Wednesday, August 14th. The company reported ($0.
40) EPS for the quarter, missing the consensus estimate of ($0.37) by ($0.03).
The company had revenue of $2.26 million for the quarter, compared to analysts’ expectations of $4.91 million.
On average, analysts expect Invivyd to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year. Invivyd Stock Up 2.3 % Shares of IVVD opened at $1.
00 on Wednesday. The company has a 50 day moving average of $0.99 and a two-hundred day moving average of $1.
32. Invivyd has a twelve month low of $0.81 and a twelve month high of $5.
20. The company has a market cap of $119.44 million, a price-to-earnings ratio of -0.
54 and a beta of 0.65. Wall Street Analyst Weigh In View Our Latest Analysis on IVVD Invivyd Company Profile ( Get Free Report ) Invivyd, Inc, a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States.
The company developed INVYMAB, a platform that combines viral surveillance and predictive modeling with advanced antibody engineering. Featured Stories Five stocks we like better than Invivyd Stock Ratings and Recommendations: Understanding Analyst Ratings Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025 Trading Stocks: RSI and Why it’s Useful Is Tesla’s Valuation a Bubble or Backed by Real Growth? What is the Dow Jones Industrial Average (DJIA)? Trucking Stocks Led the Pack Last Week: Can They Keep Rolling? Receive News & Ratings for Invivyd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invivyd and related companies with MarketBeat.com's FREE daily email newsletter .
.
